OGN (STOCKS)
Organon & Co.
$7.110000
-0.580000 (-7.54%)
Prev close: $7.690000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph T. Morrissey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,834.18M
- Employees
- 10,000
- P/E (TTM)
- 4.00
- P/B (TTM)
- 2.21
- Dividend Yield
- 442.13%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $6.30B |
| Benefits Costs and Expenses | $5.60B |
| Cost Of Revenue | $2.83B |
| Costs And Expenses | $5.60B |
| Gross Profit | $3.47B |
| Operating Expenses | $2.77B |
| Selling, General, and Administrative Expenses | $1.76B |
| Other Operating Expenses | $1.01B |
| Operating Income/Loss | $702.00M |
| Income/Loss From Continuing Operations After Tax | $501.00M |
| Income/Loss From Continuing Operations Before Tax | $702.00M |
| Income Tax Expense/Benefit | $201.00M |
| Income Tax Expense/Benefit, Deferred | $43.00M |
| Interest Expense, Operating | $515.00M |
| Net Income/Loss | $501.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $501.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $501.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.93 |
| Diluted Earnings Per Share | $1.91 |
| Basic Average Shares | 519,097,000 |
| Diluted Average Shares | 521,481,000 |
| Assets | $13.55B |
| Current Assets | $4.70B |
| Inventory | $1.49B |
| Other Current Assets | $3.21B |
| Noncurrent Assets | $8.85B |
| Fixed Assets | $1.29B |
| Other Non-current Assets | $7.56B |
| Liabilities | $12.65B |
| Current Liabilities | $2.68B |
| Accounts Payable | $1.07B |
| Other Current Liabilities | $1.61B |
| Noncurrent Liabilities | $9.97B |
| Long-term Debt | $8.83B |
| Other Non-current Liabilities | $1.14B |
| Equity | $906.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $906.00M |
| Liabilities And Equity | $13.55B |
| Net Cash Flow From Operating Activities | $949.00M |
| Net Cash Flow From Operating Activities, Continuing | $949.00M |
| Net Cash Flow From Investing Activities | -$621.00M |
| Net Cash Flow From Investing Activities, Continuing | -$621.00M |
| Net Cash Flow From Financing Activities | -$456.00M |
| Net Cash Flow From Financing Activities, Continuing | -$456.00M |
| Exchange Gains/Losses | $37.00M |
| Net Cash Flow | -$91.00M |
| Net Cash Flow, Continuing | -$128.00M |
| Comprehensive Income/Loss | $498.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $498.00M |
| Other Comprehensive Income/Loss | -$3.00M |
| Other Comprehensive Income/Loss Attributable To Parent | -$3.00M |